TokenPost·
Rapport Therapeutics Shares Drop 24% After Pricing About $355 Million in Offerings
The package includes two common-stock transactions and $150 million in convertible senior notes due in 2032.
More news
- TokenPostGold and Silver Prices Rise as Gate Places in Top Three on Oct. 28
- Bitcoin.com NewsMajor Banks Sign on as DTCC Launches Tokenized Securities Service
- Bitcoin MagazineGalaxy Asset Management: “Now Is The Time” to Buy Bitcoin
- TokenPostInternational Paper Reports $1.097 Billion Q3 Continuing-Operations Loss
- TokenPostNasdaq Leads Mixed U.S. Stock Open With 0.43% Gain Wednesday
- Crypto BriefingTreasury, SEC, CFTC to address crypto regulation gaps after CLARITY Act fails